Alphabet Q3 Revenue $127.6B; Free Cash Flow Negative

AstraZeneca Reports Q3 Revenue of $16.21 Billion; Oncology Rises 17% The headline also reports a decline for Farxiga and an Etcamah miss; it does not specify what Etcamah missed. M impact | EQUITY | Oct 31, 2026, 08:04 AM UTC

BP Posts Record Q3 Profit, Cuts Net Debt to $13.9 Billion M impact | EQUITY | Oct 31, 2026, 08:01 AM UTC

TTE Plans Buybacks, Sets Gas Target and 50% OPL257 Interest The headline says TTE plans buybacks, targets an additional 1 Bcf/d of gas and has a 50% interest in OPL257; no further details are provided. M impact | EQUITY | Oct 31, 2026, 08:01 AM UTC

Mondelez Expects Chocolate Sales to Accelerate in Brazil After Price Increases M impact | EQUITY | Oct 31, 2026, 07:41 AM UTC

Kenvue Reports Higher Third-Quarter Profit and Revenue, Awaits Kimberly-Clark Deal Closing Kenvue reported increases in profit and revenue for the third quarter and is awaiting completion of its acquisition by Kimberly-Clark. M impact | EQUITY | Oct 31, 2026, 07:41 AM UTC

Caterpillar Reports Q3 Revenue of $20.7 Billion M impact | EQUITY | Oct 31, 2026, 07:02 AM UTC

Alphabet Q3 Revenue $127.6B; Free Cash Flow Negative

Related stories